ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS · Real-Time Price · USD
2.450
+0.010 (0.41%)
Jul 11, 2025, 1:34 PM - Market open
ReShape Lifesciences Employees
As of December 31, 2024, ReShape Lifesciences had 18 total employees, including 17 full-time and 1 part-time employees. The number of employees decreased by 13 or -41.94% compared to the previous year.
Employees
18
Change (1Y)
-13
Growth (1Y)
-41.94%
Revenue / Employee
$398,611
Profits / Employee
-$192,389
Market Cap
5.85M
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
RSLS News
- 10 days ago - ReShape Lifesciences® Granted U.S. Patent Related to an Intragastric Balloon System - GlobeNewsWire
- 14 days ago - ReShape Lifesciences® Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement - GlobeNewsWire
- 15 days ago - ReShape Lifesciences® Announces Strategic Cost Reductions and Provides Update on the Merger Agreement with Vyome Therapeutics and Asset Purchase Agreement with Biorad Medisys - GlobeNewsWire
- 16 days ago - ReShape Lifesciences® Granted Key International Patent in Australia for Its Proprietary Diabetes Neuromodulation Technology - GlobeNewsWire
- 4 weeks ago - ReShape Lifesciences® Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD Markets - GlobeNewsWire
- 4 weeks ago - ReShape Lifesciences® Announces Pricing of $2.6 Million Public Offering - GlobeNewsWire
- 5 weeks ago - ReShape Lifesciences® Announces EU MDR Certification for Entire European and United Kingdom Product Portfolio - GlobeNewsWire
- 7 weeks ago - ReShape Lifesciences® Reports First Quarter Ended March 31, 2025 Financial Results and Provides Corporate Update - GlobeNewsWire